Veracyte (VCYT) Stock Price Target 2026

The average analyst price target for Veracyte is $50.21, 107.8% above the current price. Of 12 analysts, 8 rate it Buy, 3 Hold and 1 Sell. Targets range from $35 to $66. The latest change came on Nov 5, 2026, when Leerink Partners downgraded Veracyte from Outperform to Market Perform and moved its price target from $55 to $35.

The Average Analyst Price Target for Veracyte is $50.21.

Price Target Range — 12 Quarters

Analyst Consensus — 12 Analysts

8Buy

3Hold

1Sell

Consensus RatingBuy# Analysts12Avg. Consensus PT$50.21Upside to Avg. PT+107.8%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Veracyte Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Leerink Partners	Puneet Souda	Downgrade	Outperform→Market Perform	$55→$35
Nov 5, 2026	Needham	Mike Matson	PT Cut	Buy	$69→$46
Sep 15, 2026	Freedom Capital Markets	Keith Hinton	Maintained	Buy	$66
Sep 9, 2026	UBS	Doug Schenkel	PT Raise	Buy	$52→$65
Aug 4, 2026	Piper Sandler	David Westenberg	PT Cut	Overweight	$66→$54
Aug 4, 2026	Stephens & Co.	Mason Carrico	PT Cut	Overweight	$68→$55
Aug 4, 2026	Morgan Stanley	Tejas Savant	PT Cut	Underweight	$47→$44
Aug 3, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$60→$50
Jul 31, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 30, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 15, 2026	Piper Sandler	David Westenberg	Initiate	Overweight	$66
Jul 14, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$42→$60
Jul 9, 2026	Morgan Stanley	Tejas Savant	PT Raise	Underweight	$37→$47
Jun 29, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$45→$65
Jun 1, 2026	Needham	Mike Matson	PT Raise	Buy	$48→$57
May 28, 2026	Needham	Mike Matson	Maintained	Buy	$48
May 6, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$40→$42
May 6, 2026	UBS	Lu Li	PT Raise	Buy	$48→$52
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$43→$40
Apr 13, 2026	Jefferies	Tycho Peterson	Initiate	Buy	$45